Professional Media briefs

Everyday Health has teamed up with the American Heart Association with the objective of disseminating the latest cardiovascular news to HCPs through Everyday Health's medical news website for professionals, MedPage Today. In accordance with the terms of the partnership, a daily newsletter—titled “Cardiovascular Daily,” which launched in July—will be distributed via email to the 200,000-plus HCPs who have opted-in by way of AmericanHeart.org.

Quadrant HealthCom Inc. has issued a redesign of the cover of The Female Patient. “The cover redesign has a crisper look, is more user-friendly and most of all, reflects The Female Patient's mission of providing evidence-based medicine that its' readers can use in their everyday practice of caring for the female patient,” says group publisher Margo Ullmann.

Elsevier has announced the expansion of its SciVal Funding program abroad, to enable institutions to recognize opportunities for international research funding. Researchers, research administrators and research development professionals in Canada, the UK and the EU will now have access to relevant funding opportunities and will be awarded grant data under a single integrated solution.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.